toripalimab,cisplatin,temozolomide
junshi biosciences,coherus
['cisplatin', 'toripalimab', 'melanoma', 'temozolomide']
abstract number: 9508 #temozolomide plus #cisplatin versus #toripalimab (anti-pd-1) as adjuvant therapy in resected mucosal melanoma. #melanoma #asco23 #asco2023 #pd1 
Biomedical Science that Inspires. #medicine #medtwitter #meded #Science #Research #Technology #News